LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 3 of total 3

Search options

  1. Article ; Online: UGT1A1

    Peeters, Sofía Lj / Deenen, Maarten J / Thijs, Anna Mj / Hulshof, Emma C / Mathijssen, Ron Hj / Gelderblom, Hans / Guchelaar, Henk-Jan / Swen, Jesse J

    Pharmacogenomics

    2023  Volume 24, Issue 8, Page(s) 435–439

    Abstract: Tweetable abstract ... ...

    Abstract Tweetable abstract Pretreatment
    MeSH term(s) Humans ; Irinotecan/adverse effects ; Camptothecin/adverse effects ; Patient Safety ; Genotype ; Neoplasms/drug therapy ; Glucuronosyltransferase/genetics
    Chemical Substances Irinotecan (7673326042) ; Camptothecin (XT3Z54Z28A) ; Glucuronosyltransferase (EC 2.4.1.17)
    Language English
    Publishing date 2023-07-20
    Publishing country England
    Document type Editorial
    ZDB-ID 2019513-8
    ISSN 1744-8042 ; 1462-2416
    ISSN (online) 1744-8042
    ISSN 1462-2416
    DOI 10.2217/pgs-2023-0096
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 5247: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
    Jg. 1995 - 2021: Lesesall (2.OG)
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  2. Article: Phenotype-guided targeted therapy based on functional signal transduction pathway activity in recurrent ovarian cancer patients: The STAPOVER study protocol.

    van der Ploeg, Phyllis / Hendrikse, Cynthia Se / Thijs, Anna Mj / Westgeest, Hans M / Smedts, Huberdina Pm / Vos, M Caroline / Jalving, Mathilde / Lok, Christianne Ar / Boere, Ingrid A / van Ham, Maaike Apc / Ottevanger, Petronella B / Westermann, Anneke M / Mom, Constantijne H / Lalisang, Roy I / Lambrechts, Sandrina / Bekkers, Ruud Lm / Piek, Jurgen Mj

    Heliyon

    2023  Volume 10, Issue 1, Page(s) e23170

    Abstract: Objective: Ovarian cancer is the fifth cause of cancer-related death among women. The benefit of targeted therapy for ovarian cancer patients is limited even if treatment is stratified by molecular signature. There remains a high unmet need for ... ...

    Abstract Objective: Ovarian cancer is the fifth cause of cancer-related death among women. The benefit of targeted therapy for ovarian cancer patients is limited even if treatment is stratified by molecular signature. There remains a high unmet need for alternative diagnostics that better predict targeted therapy, as current diagnostics are generally inaccurate predictors. Quantitative assessment of functional signal transduction pathway (STP) activity from mRNA measurements of target genes is an alternative approach. Therefore, we aim to identify aberrantly activated STPs in tumour tissue of patients with recurrent ovarian cancer and start
    Study design: Patients with recurrent ovarian cancer and either 1) have platinum-resistant disease, 2) refrain from standard therapy or 3) are asymptomatic and not yet eligible for standard therapy will be included in this multi-centre prospective cohort study with multiple stepwise executed treatment arms. Targeted therapy will be available for patients with aberrantly high functional activity of the oestrogen receptor, androgen receptor, phosphoinositide 3-kinase or Hedgehog STP. The primary endpoint of this study is the progression-free survival (PFS) ratio (PFS2/PFS1 ratio) according to RECIST 1.1 determined by the PFS on matched targeted therapy (PFS2) compared to PFS on prior therapy (PFS1). Secondary endpoints include among others best overall response, overall survival, side effects, health-related quality of life and cost-effectiveness.
    Conclusion: The results of this study will show the clinical applicability of STP activity in selecting recurrent ovarian cancer patients for effective therapies.
    Language English
    Publishing date 2023-12-01
    Publishing country England
    Document type Journal Article
    ZDB-ID 2835763-2
    ISSN 2405-8440
    ISSN 2405-8440
    DOI 10.1016/j.heliyon.2023.e23170
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  3. Article ; Online: Repetitive electrostatic pressurised intraperitoneal aerosol chemotherapy (ePIPAC) with oxaliplatin as a palliative monotherapy for isolated unresectable colorectal peritoneal metastases: protocol of a Dutch, multicentre, open-label, single-arm, phase II study (CRC-PIPAC).

    Rovers, Koen P / Lurvink, Robin J / Wassenaar, Emma Ce / Kootstra, Thomas Jm / Scholten, Harm J / Tajzai, Rudaba / Deenen, Maarten J / Nederend, Joost / Lahaye, Max J / Huysentruyt, Clément Jr / van 't Erve, Iris / Fijneman, Remond Ja / Constantinides, Alexander / Kranenburg, Onno / Los, Maartje / Thijs, Anna Mj / Creemers, Geert-Jan M / Burger, Jacobus Wa / Wiezer, Marinus J /
    Boerma, Djamila / Nienhuijs, Simon W / de Hingh, Ignace Hjt

    BMJ open

    2019  Volume 9, Issue 7, Page(s) e030408

    Abstract: Introduction: Repetitive electrostatic pressurised intraperitoneal aerosol chemotherapy with oxaliplatin (ePIPAC-OX) is offered as a palliative treatment option for patients with isolated unresectable colorectal peritoneal metastases (PM) in several ... ...

    Abstract Introduction: Repetitive electrostatic pressurised intraperitoneal aerosol chemotherapy with oxaliplatin (ePIPAC-OX) is offered as a palliative treatment option for patients with isolated unresectable colorectal peritoneal metastases (PM) in several centres worldwide. However, little is known about its feasibility, safety, tolerability, efficacy, costs and pharmacokinetics in this setting. This study aims to explore these parameters in patients with isolated unresectable colorectal PM who receive repetitive ePIPAC-OX as a palliative monotherapy.
    Methods and analysis: This multicentre, open-label, single-arm, phase II study is performed in two Dutch tertiary referral hospitals for the surgical treatment of colorectal PM. Eligible patients are adults who have histologically or cytologically proven isolated unresectable PM of a colorectal or appendiceal carcinoma, a good performance status, adequate organ functions and no symptoms of gastrointestinal obstruction. Instead of standard palliative treatment, enrolled patients receive laparoscopy-controlled ePIPAC-OX (92 mg/m
    Ethics and dissemination: This study is approved by an ethics committee, the Dutch competent authority and the institutional review boards of both study centres. Results are intended for publication in peer-reviewed medical journals and for presentation to patients, healthcare professionals and other stakeholders.
    Trial registration number: NCT03246321, Pre-results; ISRCTN89947480, Pre-results; NTR6603, Pre-results; EudraCT: 2017-000927-29, Pre-results.
    MeSH term(s) Aerosols ; Antineoplastic Agents/administration & dosage ; Clinical Trials, Phase II as Topic ; Colorectal Neoplasms/pathology ; Humans ; Multicenter Studies as Topic ; Nebulizers and Vaporizers ; Netherlands ; Oxaliplatin/administration & dosage ; Palliative Care ; Peritoneal Neoplasms/drug therapy ; Peritoneal Neoplasms/secondary ; Pneumoperitoneum, Artificial ; Static Electricity
    Chemical Substances Aerosols ; Antineoplastic Agents ; Oxaliplatin (04ZR38536J)
    Language English
    Publishing date 2019-07-27
    Publishing country England
    Document type Clinical Trial Protocol ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2599832-8
    ISSN 2044-6055 ; 2044-6055
    ISSN (online) 2044-6055
    ISSN 2044-6055
    DOI 10.1136/bmjopen-2019-030408
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

To top